Immunotherapy for recurrent miscarriage-Reference-Cited by-同舟云学术

Immunotherapy for recurrent miscarriage

Published:2006-04-19 Issue: Volume: Page:
ISSN:
Container-title:Cochrane Database of Systematic Reviews
language:
Short-container-title:

Author:

Porter T Flint,LaCoursiere Yvette,Scott James R

Publisher

John Wiley & Sons, Ltd

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD000112.pub2/epdf/full

Reference88 articles.

1. Abstracts of Contributors' Individual Data Submitted to the Worldwide Prospective Observation Study on Immunotherapy for Treatment of Recurrent Spontaneous Abortion;Cauchi;American Journal of Reproductive Immunology,1994

2. Treatment of recurrent aborters by immunization with paternal cells - controlled trial;Cauchi;American Journal of Reproductive Immunology,1991

3. Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions;Christiansen;Fertility and Sterility,1992

4. Placebo-controlled trial of active immunization with third party leukocytes in recurrent miscarriage;Christiansen;Acta Obstetricia et Gynecologica Scandinavica,1994

5. Intravenous immunoglobulin treatment of women with recurrent miscarriage;Christiansen;Acta Obstetricia et Gynecologica Scandinavica,1997

Cited by 131 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and immunological criteria for the use of intravenous immunoglobulins in women with reproductive failures;Journal of obstetrics and women's diseases;2023-09-28

2. Pregnancy by Oocyte Donation: Reviewing Fetal–Maternal Risks and Complications;International Journal of Molecular Sciences;2023-09-11

3. The Diagnostics and Treatment of Recurrent Pregnancy Loss;Journal of Clinical Medicine;2023-07-19

4. Investigation and Management of Recurrent Pregnancy Loss: A Comprehensive Review of Guidelines;Obstetrical & Gynecological Survey;2023-05

5. Tacrolimus improved the pregnancy outcomes of patients with refractory recurrent spontaneous abortion and immune bias disorders: a randomized controlled trial;European Journal of Clinical Pharmacology;2023-03-13